MedPath

Pivot Breath Sensor Human Factors and Usability Study

Not Applicable
Completed
Conditions
Smoking, Tobacco
Smoking Cessation
Interventions
Device: Pivot Breath Sensor
Registration Number
NCT03835260
Lead Sponsor
Jennifer Marler, MD
Brief Summary

Prospective, observational open label, single center study enrolling up to 15 subjects to evaluate human factors and usability of the Pivot Breath Sensor.

Detailed Description

The objectives of this Human Factors/Usability study are to:

* Ensure that representative intended users are able to operate the Pivot Breath Sensor independently

* Validate appropriate mitigations of use related hazards identified in risk management documentation

* Uncover previously unforeseen use errors

This human factors and usability testing is conducted to demonstrate that the Pivot Breath Sensor can be used by the intended users without serious use errors or problems, for the intended uses and under the expected use conditions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • 18-80 years of age
  • English speaking
  • Owns and uses a smartphone
  • Willing to sign the Informed Consent Form
Exclusion Criteria
  • Prior experience with a study sponsored by Carrot Inc
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pivot Breath Sensor (user group)Pivot Breath SensorSelf-reported daily smokers of 2 or more cigarettes per day
Primary Outcome Measures
NameTimeMethod
Human Factors - User Performance in Use Scenarios Assessment With Observer RatingsEach study session was completed on a single day, for up to 60 minutes. Device set up was assessed at about 5 minutes in. Device use was assessed at about 10 minutes in. Interpretation of results was assessed at about 15 and 20 minutes in.

User performance of participants in intended use scenarios will be assessed at a single visit. Participants will be observed if they can set up the device, use the device, and interpret results. Observer ratings include 'Successful' and 'Unsuccessful'. Specific attention will be given to assess if any harms can occur from observed use errors.

'Successful' = user was able to complete the task safely and effectively. Unsuccessful' = user was unable unable to complete the task independently or did not complete the task safely and effectively.

For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 60 minutes.

Observations are made throughout the study session. Assessments for individual tasks will take approximately 1 minute and assessments will be made over the study session which can last up to 60 minutes.

Human Factors - User Documentation Assessment With Observer RatingsEach study session was completed on a single day, for up to 60 minutes. The user documentation assessment occurred at approximately 30 minutes into the study session.

Participant understanding of user documentation will be assessed at single visit. User documentation includes packaging information, quick start guide and user manual. Observer ratings include 'Successful' and 'Unsuccessful'.

'Successful' = user was able to complete the task safely and effectively. Unsuccessful' = user was unable unable to complete the task independently or did not complete the task safely and effectively.

For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 60 minutes.

Observations are made throughout the study session. Assessments for individual tasks will take approximately 1 minute each. The User documentation assessment portion of the study session will last up to 30 minutes.

Human Factors - Subjective Feedback QuestionnaireEach study session was completed on a single day, for up to 60 minutes. The subjective feedback questionnaire was administered at approximately 40 minutes into the study session.

Subjective feedback focusing on any concerns on using device will be assessed at single visit. Participants will answer with a Yes or No to the questions.

For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 60 minutes.

Subjective feedback focusing on any concerns prior to the conclusion of the study session. Subjective feedback questions will take approximately 1-3 minutes each. The Subjective feedback portion of the study session will last up to 5 to 15 minutes.

Human Factors - Participant Feedback Using Rating ScaleEach study session was completed on a single day, for up to 60 minutes. Participant feedback using a rating scale was provided at approximately 50 minutes into the study session.

Participant will be asked to provide ratings on the following:

* How would you rate the ease or difficulty using the device?

* How clear or unclear was the Quick Start Guide?

* How clear or unclear was the Packaging?

* How clear or unclear was the User Manual?

* How easy or difficult was it to understand and interpret the test results?

The participant will use the following rating scale (higher score = better outcome):

5 - Very Easy 4 - Easy 3 - Neither Easy nor Difficult 2 - Difficult

1 - Very difficult

For each participant, the single visit includes the consent process, entry into the study, the study session, and conclusion of the study. The study session is completed on a single day requiring up to 60 minutes.

Participant will provide the ratings prior to the conclusion of the study session. Participant assessment with questionnaire rating scales will take approximately 1-2 minutes each.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Carrot Inc.

🇺🇸

Redwood City, California, United States

Carrot Inc.
🇺🇸Redwood City, California, United States
© Copyright 2025. All Rights Reserved by MedPath